Quick Answer
Regenerative Medical Technology Group Inc. reported Stockholders Equity of -$27.36 million for fiscal year 2024.
Regenerative Medical Technology Group Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2024 | -$27.36M | -25.5% |
| 2023 | -$21.80M | -81.9% |
| 2022 | -$11.98M | -77.3% |
| 2021 | -$6.76M | -5.4% |
| 2020 | -$6.41M | +12.9% |
| 2019 | -$7.36M | -62.1% |
| 2018 | -$4.54M | -77.2% |
| 2017 | -$2.56M | +53.5% |
| 2016 | -$5.51M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$30.05M | -12.5% | -3.6% |
| June 30, 2025 | -$29.02M | -12.3% | -3.2% |
| March 31, 2025 | -$28.12M | -18.4% | -2.8% |
| December 31, 2024 | -$27.36M | -25.5% | -2.4% |
| September 30, 2024 | -$26.72M | -24.0% | -3.4% |
| June 30, 2024 | -$25.83M | -64.7% | -8.7% |
| March 31, 2024 | -$23.76M | -74.0% | -9.0% |
| December 31, 2023 | -$21.80M | -81.9% | -1.2% |
- Regenerative Medical Technology Group Inc. showed a decrease of -25.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2016–2024 period, Regenerative Medical Technology Group Inc.’s stockholders equity has declined by 396.7% (from -$5.51 million to -$27.36 million).
- The most recent figure is from Regenerative Medical Technology Group Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on April 15, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: